New York
How Blue Chip Stamps v. Manor Drug Stores applies in New York: state-specific rules, key cases, and bar exam notes for Securities Law.
New York law reflects the principles established in Blue Chip Stamps, particularly regarding standing to sue in securities fraud cases. Plaintiffs in New York must demonstrate that they are entitled to assert claims under the specific provisions of the Martin Act or federal securities law, reinforcing the need for direct purchasers or sellers rather than mere traders.
In New York, only actual purchasers or sellers of securities have standing to sue for securities fraud, consistent with the holding in Blue Chip Stamps.
The court ruled that only those who purchased shares directly have the right to claim for damages under securities fraud statutes.
Court emphasized that mere lack of knowledge regarding fraudulent activity does not grant standing to passive investors.
Court upheld the requirement for direct participation in the buy/sell transaction to sue under New York securities law.
While federal securities law allows for a broader interpretation concerning damages and class actions, New York strictly adheres to the standing principle as defined in Blue Chip Stamps. New York courts emphasize a direct transactional relationship to establish standing, making it more restrictive than federal requirements.
Candidates should understand the implications of standing under New York securities law and be prepared for questions that test the application of Blue Chip Stamps principles in the context of New York jurisdiction.